Lataa...
ENDPOINTS AND CLINICAL TRIAL DESIGN FOR NONALCOHOLIC STEATOHEPATITIS
Nonalcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease in the general population. Nonalcoholic steatohepatitis (NASH), the aggressive form of NAFLD, is associated with an increased risk of liver-related mortality and cardiovascular disease. Currently, a liver biopsy is t...
Tallennettuna:
| Päätekijät: | , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2011
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4014460/ https://ncbi.nlm.nih.gov/pubmed/21520200 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.24376 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|